Panel Discussion – A European Industry & Regulatory Perspective Into the Development & Route to Approval for Personalised mRNA Cancer Therapies
Time: 5:15 pm
day: Day 1 PM
Details:
- Uncovering how successful mRNA cancer vaccine trials are selecting patients and achieving clinical endpoints
- How to reduce the personalised cancer vaccine timeline by central manufacturing and optimised logistics Navigating the regulatory frameworks for personalised medicine to ensure success post-approval
- Navigating the regulatory frameworks for personalised medicine to ensure success post-approval
